A democratic order is the best form of governance because it promotes transparency, that makes it possible to fix ...

ZoomInfo reports that 63% of corporate strategy value doesn't materialize due to execution gaps, costing $2 trillion in lost ...

As part of the nationwide initiative to realise the vision of Viksit Bharat, Chief Secretary, Atal Dulloo on Sunday chaired a ...

Dear Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties : As we prepare to end 2025, we would like to provide you with this open letter summarizing our ...

Relmada Therapeutics is advancing NDV-01, a novel intravesical therapy for NMIBC, into phase 3 clinical trials, with Max ...

MediWound Ltd. (NASDAQ: MDWD) Q3 2025 Earnings Call Transcript November 20, 2025 MediWound Ltd. beats earnings expectations.

On November 13, 2025, effective November 14, 2025 the Securities and Exchange Commission (“Commission”), in Administrative Proceeding File No. 3-22541, in Release No. 104178 issued an Order Making ...

Jefferies London Healthcare Conference 2025 November 19, 2025 4:30 AM ESTCompany ParticipantsTony Wood - Chief Scientific Officer and Head ...

The first wave of Commissioner’s National Priority Vouchers signals a fundamental shift in FDA competitiveness, rewarding companies that pair breakthrough science with affordability commitments, ...

Neurocrine Biosciences, Inc. ( NBIX) Jefferies London Healthcare Conference 2025 November 18, 2025 7:00 AM EST Hi, everyone. My name is Phoebe Tan, and I am an Associate on Akash Tewari's team. And ...

Q3 2025 Management View Matthew Duffy, Chief Business Officer & Co-CEO of Hope Therapeutics, opened the call stating, "Since the beginning of the third quarter, NRx has made transformative progress in ...

Canadian manufacturing, long stereotyped as focused on resource extraction and commodity production, has pockets of genuine world-class sophistication. In specialized sectors like precision ...